Avidas Pharmaceuticals, a specialty pharmaceutical company which focuses on dermatology and women’s health, has launched the Scalacort defence kit that offers three scalp solutions in one patient convenience
Dor BioPharma, an R&D biopharmaceutical company, has entered into a $400,000 common stock equity investment agreement priced at market with its clinical trials management partner, Numoda, a provider
Australia-based biotechnology company Avexa has reported that the last patient enrolled in the initial two dose phase of the apricitabine Phase III trial has passed the week 16
Novavax intends to use the $11 million in gross proceeds from this investment to pay a portion of its 4.75% senior convertible notes due in July 2009 and
According to SunTech, its AccuWin Pro v3 software supports the company’s Oscar 2 ambulatory blood pressure monitor. The release offers various upgrades including new compatibility features for Windows
The transaction will generate cash proceeds of approximately $275 million from the sale of property and equipment. Approximately $30 million from these proceeds will be deferred and placed
According to Roche, the LightCycler MRSA advanced test is a qualitative in vitro diagnostic test for the direct detection of nasal colonization with MRSA. The test will aid
Under the GW-Almirall contract, this milestone payment became due in the event that GW obtained positive results in its recent Sativex multiple sclerosis spasticity Phase III trial and,
Abbott has announced that data from a new study showed that Trilipix delayed-release capsules in combination with rosuvastatin calcium met all of the study’s primary endpoints. Trilipix 135mg
Mr Bury joins Cyprotex from Shanghai ChemPartner, where he was director of business development and responsible for growing the company’s European preclinical services business. He previously held the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.